Psychiatric Neuropathology Group
The group is engaged in research to elucidate the changes in brain chemistry associated with psychiatric disorders. A better understanding of the chemical imbalances that occur with disorders such as schizophrenia, bipolar disorder and major depressive disorder will be the foundation for the design of more effective targeted therapies for people with the disorder.
The group undertakes research, predominantly using brain, blood and other tissue samples, as well as a variety of other approaches including cell culture and animal studies, to identify changes in the brain chemistry of people. In addition to finding changes in the brain chemistry, the group tries to determine the causes and consequences of these changes to create a biochemical snapshot of what is happening in the brains of people with psychiatric disorders.
- Professor Ian Everall
- Professor Stan Skafidas
- Professor Chris Pantelis
- Dr Sandra Luza
- Dr Carlos Opazo Martinez
- Professor Ashley Bush
- Dr Chad Chad Bousman
- Chengxing Liu PhD Student
Shaki Mostaid PhD Student
- The Florey Institute of Neuroscience and Mental Health
- Proteomic profiles of psychotic symptom severity
- The role of the ubiquitin proteasome system in schizophrenia
Areas of Excellence
Neuroscience and Psychiatry
For further information about this research, please contact
Professor Ian Everall.